TScan Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TScan Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q2 2024.
  • TScan Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $60.9M, a 1.89% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $60.9M +$1.13M +1.89% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $62.2M +$4.32M +7.46% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $63.5M +$4.39M +7.43% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $58.5M +$54.2M +1240% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $59.8M +$55.1M +1159% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $57.9M +$52.8M +1030% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $59.1M +$53.6M +976% Dec 31, 2022 10-K 2024-03-06
Q3 2022 $4.37M -$1.46M -25.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $4.75M -$1.44M -23.2% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $5.13M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $5.49M -$1.38M -20.1% Dec 31, 2021 10-K 2023-03-08
Q3 2021 $5.83M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $6.19M Jun 30, 2021 10-Q 2021-08-19
Q4 2020 $6.87M Dec 31, 2020 10-K 2022-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.